  | Turner, M. C., Radzikowska, U., Ferastraoaru, D. E., Pascal, M., Wesseling, P., McCraw, A., BACKES, C., Bax, H. J., Bergmann, C., Bianchini, R., Cari, L., de Las Vecillas, L., Izquierdo, E., Lind-Holm Mogensen, F., MICHELUCCI, A., NAZAROV, P., NICLOU, S. P., Nocentini, G., OLLERT, M., ... Poli, A. (2024). AllergoOncology: Biomarkers and refined classification for research in the allergy and glioma nexus-A joint EAACI-EANO position paper. Allergy. doi:10.1111/all.15994  Peer Reviewed verified by ORBi |
 | Oudin, A., Moreno-Sanchez, P. M., Baus, V., NICLOU, S. P., & GOLEBIEWSKA, A. (02 January 2024). Magnetic resonance imaging-guided intracranial resection of glioblastoma tumors in patient-derived orthotopic xenografts leads to clinically relevant tumor recurrence. BMC Cancer, 24 (1), 3. doi:10.1186/s12885-023-11774-6 Peer Reviewed verified by ORBi |
 | Erasimus, H., GOBIN, M., NICLOU, S. P., & Van Dyck, E. (2024). DNA repair mechanisms and their clinical impact in glioblastoma. Mutation Research - Reviews in Mutation Research, 769, 19-35. doi:10.1016/j.mrrev.2016.05.005 Peer Reviewed verified by ORBi |
NICLOU, S. P., Ehlert, E. M. E., & Verhaagen, J. (2024). Chemorepellent axon guidance molecules in spinal cord injury. Journal of Neurotrauma, 23 (3-4), 409-21. doi:10.1089/neu.2006.23.409 Peer Reviewed verified by ORBi |
 | Nesseler, J. P., Schaue, D., McBride, W. H., Lee, M.-H., Kaprealian, T., NICLOU, S. P., & Nickers, P. (2024). Irradiation to Improve the Response to Immunotherapeutic Agents in Glioblastomas. Advances in Radiation Oncology, 4 (2), 268-282. doi:10.1016/j.adro.2018.11.005 Peer Reviewed verified by ORBi |
 | Cano-Galiano, A., Oudin, A., Fack, F., Allega, M.-F., Sumpton, D., Martinez-Garcia, E., DITTMAR, G., Hau, A.-C., De Falco, A., Herold-Mende, C., Bjerkvig, R., MEISER, J., Tardito, S., & NICLOU, S. P. (2024). Cystathionine-γ-lyase drives antioxidant defense in cysteine-restricted IDH1-mutant astrocytomas. Neuro-Oncology Advances, 3 (1), 057. doi:10.1093/noajnl/vdab057 Peer Reviewed verified by ORBi |
 | Nassiri, F., Aldape, K., Alhuwalia, M., Brastianos, P., Ducray, F., Galldiks, N., Kim, A., Lamszus, K., Mitchell, D., Nabors, L. B., Nam, D.-H., Natsume, A., Ng, H.-K., NICLOU, S. P., Sahm, F., Short, S., Walsh, K., Wick, W., & Zadeh, G. (2024). Highlights of the inaugural ten - the launch of Neuro-Oncology Advances. Neuro-Oncology Advances, 1 (1), 016. doi:10.1093/noajnl/vdz016 Peer Reviewed verified by ORBi |
 | Neirinckx, V., Hau, A.-C., Schuster, A., FRITAH, S., Tiemann, K., KLEIN, E., NAZAROV, P., Matagne, A., SZPAKOWSKA, M., MEYRATH, M. M. R., Chevigné, A., Schmidt, M. H. H., & NICLOU, S. P. (2024). The soluble form of pan-RTK inhibitor and tumor suppressor LRIG1 mediates downregulation of AXL through direct protein-protein interaction in glioblastoma. Neuro-Oncology Advances, 1 (1), 024. doi:10.1093/noajnl/vdz024 Peer Reviewed verified by ORBi |
 | Malta, T. M., Sabedot, T. S., Morosini, N. S., Datta, I., Garofano, L., Vallentgoed, W. R., Varn, F. S., Aldape, K., D'Angelo, F., Bakas, S., Barnholtz-Sloan, J. S., Gan, H. K., Hasanain, M., Hau, A.-C., Johnson, K. C., Cazacu, S., deCarvalho, A. C., Khasraw, M., Kocakavuk, E., ... Noushmehr, H. (2023). The epigenetic evolution of glioma is determined by the IDH1 mutation status and treatment regimen. Cancer Research. doi:10.1158/0008-5472.CAN-23-2093 Peer Reviewed verified by ORBi |
Yabo, Y. A., Moreno-Sanchez, P. M., Pires-Afonso, Y., Kaoma, T., Nosirov, B., Scafidi, A., Ermini, L., Lipsa, A., Oudin, A., KYRIAKIS, D., GRZYB, K., POOVATHINGAL, S. K., Poli, A., Muller, A., TOTH, R., KLINK, B., BERCHEM, G. J. M. J., Berthold, C., HERTEL, F., ... GOLEBIEWSKA, A. (2023). Glioblastoma-instructed microglia transition to heterogeneous phenotypic states with phagocytic and dendritic cell-like features in patient tumors and patient-derived orthotopic xenografts. ORBilu-University of Luxembourg. https://orbilu.uni.lu/handle/10993/60199. doi:10.1101/2023.03.05.531162 |
  | Le Rhun, E., Boele, F., Minniti, G., Galldiks, N., Taphoorn, M., Piil, K., Rudà, R., NICLOU, S. P., Geurts, M., Preusser, M., Weller, M., Short, S. C., & Dirven, L. (2023). Gender balance and suitable positive actions to promote gender equality among healthcare professionals in neuro-oncology: The EANO positive action initiative. Neuro-Oncology Practice. doi:10.1093/nop/npad064 Peer reviewed |
 | Biswas, A., Salvucci, M., Connor, K., Düssmann, H., Carberry, S., Fichtner, M., King, E., Murphy, B., O'Farrell, A. C., Cryan, J., Beausang, A., Heffernan, J., Cremona, M., Hennessy, B. T., Clerkin, J., Sweeney, K. J., MacNally, S., Brett, F., O'Halloran, P., ... Prehn, J. H. M. (June 2023). Comparative analysis of deeply phenotyped GBM cohorts of 'short-term' and 'long-term' survivors. Journal of Neuro-Oncology, 163 (2), 327-338. doi:10.1007/s11060-023-04341-3 Peer Reviewed verified by ORBi |
 | Capper, D., Reifenberger, G., French, P. J., Schweizer, L., Weller, M., Touat, M., NICLOU, S. P., Euskirchen, P., Haberler, C., Hegi, M. E., Brandner, S., Le Rhun, E., Rudà, R., Sanson, M., Tabatabai, G., Sahm, F., Wen, P. Y., Wesseling, P., Preusser, M., & van den Bent, M. J. (04 May 2023). EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selection. Neuro-Oncology, 25 (5), 813-826. doi:10.1093/neuonc/noad008 Peer Reviewed verified by ORBi |
 | Poli, A., Oudin, A., Muller, A., Salvato, I., Scafidi, A., Hunewald, O., Domingues, O., NAZAROV, P., Puard, V., Baus, V., AZUAJE, F., DITTMAR, G., ZIMMER, J., MICHEL, T., MICHELUCCI, A., NICLOU, S. P., & OLLERT, M. (March 2023). Allergic airway inflammation delays glioblastoma progression and reinvigorates systemic and local immunity in mice. Allergy, 78 (3), 682-696. doi:10.1111/all.15545 Peer Reviewed verified by ORBi |
 | NICLOU, S. P., & GOLEBIEWSKA, A. (February 2023). How to move a “fried egg”: membrane blebbing in oligodendrogliomas. Neuro-Oncology, 25 (6), 1044–1046. doi:10.1093/neuonc/noad039 Peer Reviewed verified by ORBi |
 | Pati, S., Baid, U., Edwards, B., Sheller, M., Wang, S.-H., Reina, G. A., Foley, P., Gruzdev, A., Karkada, D., Davatzikos, C., Sako, C., Ghodasara, S., Bilello, M., Mohan, S., Vollmuth, P., Brugnara, G., Preetha, C. J., Sahm, F., Maier-Hein, K., ... Bakas, S. (26 January 2023). Author Correction: Federated learning enables big data for rare cancer boundary detection. Nature Communications, 14 (1), 436. doi:10.1038/s41467-023-36188-7 Peer Reviewed verified by ORBi |
Dosquet, H., Neirinckx, V., MEYRATH, M. M. R., Wantz, M., HAAN, S., NICLOU, S. P., SZPAKOWSKA, M., & Chevigné, A. (2023). Nanoluciferase-based complementation assays to monitor activation, modulation and signaling of receptor tyrosine kinases (RTKs). In Chapter One - Nanoluciferase-based complementation assays to monitor activation, modulation and signaling of receptor tyrosine kinases (RTKs). Elsevier. doi:10.1016/bs.mie.2022.09.002 Peer Reviewed verified by ORBi |
 | Pati, S., Baid, U., Edwards, B., Sheller, M., Wang, S.-H., Reina, G. A., Foley, P., Gruzdev, A., Karkada, D., Davatzikos, C., Sako, C., Ghodasara, S., Bilello, M., Mohan, S., Vollmuth, P., Brugnara, G., Preetha, C. J., Sahm, F., Maier-Hein, K., ... Bakas, S. (05 December 2022). Federated learning enables big data for rare cancer boundary detection. Nature Communications, 13 (1), 7346. doi:10.1038/s41467-022-33407-5 Peer Reviewed verified by ORBi |
 | Pires-Afonso, Y., Muller, A., GRZYB, K., Oudin, A., Yabo, Y. A., SOUSA, C., Scafidi, A., Poli, A., COSMA, A., HALDER, R., COOWAR, D., GOLEBIEWSKA, A., SKUPIN, A., NICLOU, S. P., & MICHELUCCI, A. (September 2022). Elucidating tumour-associated microglia/macrophage diversity along glioblastoma progression and under ACOD1 deficiency. Molecular Oncology, 16 (17), 3167 - 3191. doi:10.1002/1878-0261.13287 Peer Reviewed verified by ORBi |
 | Venkataramani, V., Yang, Y., Schubert, M. C., Reyhan, E., Tetzlaff, S. K., Wißmann, N., Botz, M., Soyka, S. J., Beretta, C. A., Pramatarov, R. L., Fankhauser, L., Garofano, L., Freudenberg, A., Wagner, J., Tanev, D. I., Ratliff, M., Xie, R., Kessler, T., Hoffmann, D. C., ... Winkler, F. (04 August 2022). Glioblastoma hijacks neuronal mechanisms for brain invasion. Cell, 185 (16), 2899-2917.e31. doi:10.1016/j.cell.2022.06.054 Peer Reviewed verified by ORBi |
 | ILINA, E., CIALINI, C., GERLOFF, D., Duarte Garcia-Escudero, M., Jeanty, C., Thézénas, M.-L., Lesur, A., Puard, V., Bernardin, F., Moter, A., Schuster, A., Dieterle, M., GOLEBIEWSKA, A., GERARDY, J.-J., DITTMAR, G., NICLOU, S. P., Müller, T., & MITTELBRONN, M. (18 February 2022). Enzymatic activity of glycosyltransferase GLT8D1 promotes human glioblastoma cell migration. iScience, 25 (2), 103842. doi:10.1016/j.isci.2022.103842 Peer Reviewed verified by ORBi |
 | KISHK, A., PIRES PACHECO, M. I., HEURTAUX, T., SINKKONEN, L., PANG, J., Fritah, S., NICLOU, S., & SAUTER, T. (2022). Review of Current Human Genome-Scale Metabolic Models for Brain Cancer and Neurodegenerative Diseases. Cells, 11 (16). doi:10.3390/cells11162486 Peer Reviewed verified by ORBi |
 | Yabo, Y. A., NICLOU, S. P., & GOLEBIEWSKA, A. (December 2021). Cancer cell heterogeneity and plasticity: A paradigm shift in glioblastoma. Neuro-Oncology, 24 (5), 669–682. doi:10.1093/neuonc/noab269 Peer Reviewed verified by ORBi |
 | Sharma, A. B., Erasimus, H., Pinto, L., Caron, M.-C., Gopaul, D., Peterlini, T., Neumann, K., NAZAROV, P., FRITAH, S., KLINK, B., Herold-Mende, C. C., NICLOU, S. P., Pasero, P., Calsou, P., Masson, J.-Y., Britton, S., & Van Dyck, E. (27 September 2021). XAB2 promotes Ku eviction from single-ended DNA double-strand breaks independently of the ATM kinase. Nucleic Acids Research, 49 (17), 9906-9925. doi:10.1093/nar/gkab785 Peer Reviewed verified by ORBi |
 | Kulkarni, A., Ferreira, T., Bretscher, C., Grewenig, A., El-Andaloussi, N., Bonifati, S., Marttila, T., PALISSOT, V., Hossain, J. A., AZUAJE, F., Miletic, H., Ystaas, L. A. R., GOLEBIEWSKA, A., NICLOU, S. P., Roeth, R., Niesler, B., Weiss, A., Brino, L., & MARCHINI, A. (22 June 2021). Oncolytic H-1 parvovirus binds to sialic acid on laminins for cell attachment and entry. Nature Communications, 12 (1), 3834. doi:10.1038/s41467-021-24034-7 Peer Reviewed verified by ORBi |
 | Oudin, A., Baus, V., Barthelemy, V., Fabian, C., KLEIN, E., Dieterle, M., Wantz, M., Hau, A.-C., DORDING, C., Bernard, A., MICHELUCCI, A., Yabo, Y. A., Kanli, G., Keunen, O., Bjerkvig, R., NICLOU, S. P., & GOLEBIEWSKA, A. (18 June 2021). Protocol for derivation of organoids and patient-derived orthotopic xenografts from glioma patient tumors. STAR Protocols, 2 (2), 100534. doi:10.1016/j.xpro.2021.100534 Peer Reviewed verified by ORBi |
 | NICLOU, S. P., & GOLEBIEWSKA, A. (April 2021). Turning strength into weakness: protein degradation and autophagy as therapeutic targets in glioblastoma? Neuro-Oncology, 23 (7), 1041–1043. doi:10.1093/neuonc/noab099 Peer Reviewed verified by ORBi |
Fabian, C., Han, M., Bjerkvig, R., & NICLOU, S. P. (2021). Novel facets of glioma invasion. International Review of Cell and Molecular Biology, 360, 33-64. doi:10.1016/bs.ircmb.2020.08.001 Peer Reviewed verified by ORBi |
 | Schuster, A., KLEIN, E., Neirinckx, V., Knudsen, A. M., Fabian, C., Hau, A.-C., Dieterle, M., Oudin, A., NAZAROV, P., GOLEBIEWSKA, A., Muller, A., Perez-Hernandez, D., Rodius, S., DITTMAR, G., Bjerkvig, R., Herold-Mende, C., KLINK, B., Kristensen, B. W., & NICLOU, S. P. (11 December 2020). AN1-type zinc finger protein 3 (ZFAND3) is a transcriptional regulator that drives Glioblastoma invasion. Nature Communications, 11 (1), 6366. doi:10.1038/s41467-020-20029-y Peer Reviewed verified by ORBi |
 | White, K., Connor, K., Clerkin, J., Murphy, B. M., Salvucci, M., O'Farrell, A. C., REHM, M., O'Brien, D., Prehn, J. H. M., NICLOU, S. P., Lamfers, M. L. M., Verreault, M., Idbaih, A., Verhaak, R., GOLEBIEWSKA, A., & Byrne, A. T. (December 2020). New hints towards a precision medicine strategy for IDH wild-type glioblastoma. Annals of Oncology, 31 (12), 1679-1692. doi:10.1016/j.annonc.2020.08.2336 Peer Reviewed verified by ORBi |
 | GOLEBIEWSKA, A., Hau, A.-C., Oudin, A., Stieber, D., Yabo, Y. A., Baus, V., Barthelemy, V., Klein, E., Bougnaud, S., Keunen, O., Wantz, M., MICHELUCCI, A., Neirinckx, V., Muller, A., Kaoma, T., Nazarov, P. V., AZUAJE, F., De Falco, A., Flies, B., ... NICLOU, S. (2020). Patient-derived organoids and orthotopic xenografts of primary and recurrent gliomas represent relevant patient avatars for precision oncology. Acta Neuropathologica. doi:10.1007/s00401-020-02226-7 Peer Reviewed verified by ORBi |
 | FRITAH, S., Muller, A., Jiang, W., Mitra, R., Sarmini, M., Dieterle, M., GOLEBIEWSKA, A., Ye, T., Van Dyck, E., Herold-Mende, C., Zhao, Z., AZUAJE, F., & NICLOU, S. P. (10 September 2020). Temozolomide-Induced RNA Interactome Uncovers Novel LncRNA Regulatory Loops in Glioblastoma. Cancers, 12 (9). doi:10.3390/cancers12092583 Peer Reviewed verified by ORBi |
 | GOLEBIEWSKA, A., Hau, A.-C., Oudin, A., Stieber, D., Yabo, Y. A., Baus, V., Barthelemy, V., Klein, E., Bougnaud, S., Keunen, O., Wantz, M., MICHELUCCI, A., Neirinckx, V., Muller, A., Kaoma, T., Nazarov, P. V., AZUAJE, F., De Falco, A., Flies, B., ... NICLOU, S. (2020). Primary and recurrent glioma patient-derived orthotopic xenografts (PDOX) represent relevant patient avatars for precision medicine. ORBilu-University of Luxembourg. https://orbilu.uni.lu/handle/10993/43022. doi:10.1101/2020.04.24.057802 |
 | Keunen, O., & NICLOU, S. P. (2020). Is there a prominent role for MR spectroscopy in the clinical management of brain tumors? Neuro-Oncology. doi:10.1093/neuonc/noaa098 Peer Reviewed verified by ORBi |
 | Le Rhun, E., Weller, M., NICLOU, S. P., Short, S., Piil, K., Boele, F., Rudà, R., Theodorou, M., Brandsma, D., van den Bent, M., & Dirven, L. (March 2020). Gender issues from the perspective of health-care professionals in Neuro-oncology: an EANO and EORTC Brain Tumor Group survey. Neuro-Oncology Practice, 7 (2), 249-259. doi:10.1093/nop/npz053 Peer reviewed |
 | Rodius, S., de Klein, N., Jeanty, C., Sánchez-Iranzo, H., Crespo, I., Ibberson, M., Xenarios, I., DITTMAR, G., Mercader, N., NICLOU, S. P., & AZUAJE, F. (19 February 2020). Fisetin protects against cardiac cell death through reduction of ROS production and caspases activity. Scientific Reports, 10 (1), 2896. doi:10.1038/s41598-020-59894-4 Peer Reviewed verified by ORBi |
 | FRITAH, S., & NICLOU, S. P. (2020). Dual blockade of STAT3 and EGFR: a key to unlock drug resistance in glioblastoma? Neuro-Oncology. doi:10.1093/neuonc/noaa039 Peer Reviewed verified by ORBi |
 | Pires-Afonso, Y., NICLOU, S. P., & MICHELUCCI, A. (21 January 2020). Revealing and Harnessing Tumour-Associated Microglia/Macrophage Heterogeneity in Glioblastoma. International Journal of Molecular Sciences, 21 (3). doi:10.3390/ijms21030689 Peer Reviewed verified by ORBi |
 | KLEIN, E., Hau, A.-C., Oudin, A., GOLEBIEWSKA, A., & NICLOU, S. P. (2020). Glioblastoma Organoids: Pre-Clinical Applications and Challenges in the Context of Immunotherapy. Frontiers in Oncology, 10, 604121. doi:10.3389/fonc.2020.604121 Peer Reviewed verified by ORBi |
 | Biedermann, J., Preussler, M., Conde, M., Peitzsch, M., Richter, S., Wiedemuth, R., Abou-El-Ardat, K., Krüger, A., Meinhardt, M., Schackert, G., Leenders, W. P., Herold-Mende, C., NICLOU, S. P., Bjerkvig, R., Eisenhofer, G., Temme, A., Seifert, M., Kunz-Schughart, L. A., Schröck, E., & KLINK, B. (16 December 2019). Mutant IDH1 Differently Affects Redox State and Metabolism in Glial Cells of Normal and Tumor Origin. Cancers, 11 (12). doi:10.3390/cancers11122028 Peer Reviewed verified by ORBi |
 | Barthel, F. P., Johnson, K. C., Varn, F. S., Moskalik, A. D., Tanner, G., Kocakavuk, E., Anderson, K. J., Abiola, O., Aldape, K., Alfaro, K. D., Alpar, D., Amin, S. B., Ashley, D. M., Bandopadhayay, P., Barnholtz-Sloan, J. S., Beroukhim, R., Bock, C., Brastianos, P. K., Brat, D. J., ... Verhaak, R. G. W. (Other coll.). (December 2019). Longitudinal molecular trajectories of diffuse glioma in adults. Nature, 576 (7785), 112-120. doi:10.1038/s41586-019-1775-1 Peer Reviewed verified by ORBi |
 | Zeiner, P. S., Preusse, C., GOLEBIEWSKA, A., Zinke, J., Iriondo, A., Muller, A., Kaoma, T., Filipski, K., Müller-Eschner, M., Bernatz, S., Blank, A.-E., Baumgarten, P., ILINA, E., Grote, A., Hansmann, M. L., Verhoff, M. A., Franz, K., Feuerhake, F., Steinbach, J. P., ... MITTELBRONN, M. (July 2019). Distribution and prognostic impact of microglia/macrophage subpopulations in gliomas. Brain Pathology, 29 (4), 513-529. doi:10.1111/bpa.12690 Peer Reviewed verified by ORBi |
 | Reynders, Abboud, Baragli, Noman, Rogister, NICLOU, S. P., Heveker, JANJI, B., Hanson, SZPAKOWSKA, M., & Chevigné. (June 2019). The Distinct Roles of CXCR3 Variants and Their Ligands in the Tumor Microenvironment. Cells, 8 (6), 613. doi:10.3390/cells8060613 Peer Reviewed verified by ORBi |
 | GOBIN, M., NAZAROV, P., Warta, R., Timmer, M., Reifenberger, G., Felsberg, J., Vallar, L., Chalmers, A. J., Herold-Mende, C. C., Goldbrunner, R., NICLOU, S. P., & Van Dyck, E. (15 March 2019). A DNA Repair and Cell-Cycle Gene Expression Signature in Primary and Recurrent Glioblastoma: Prognostic Value and Clinical Implications. Cancer Research, 79 (6), 1226-1238. doi:10.1158/0008-5472.CAN-18-2076 Peer Reviewed verified by ORBi |
 | Dirkse, A., Golebiewska, A., Buder, T., Nazarov, P. V., Muller, A., Poovathingal, S., Brons, N. H. C., Leite, S., Sauvageot, N., Sarkisjan, D., Seyfrid, M., Fritah, S., Stieber, D., MICHELUCCI, A., Herold-Mende, C., Bjerkvig, R., Azuaje, F., SKUPIN, A., Deutsch, A., ... Hertel, F. (2019). Stem cell-associated heterogeneity in Glioblastoma results from intrinsic tumor plasticity shaped by the microenvironment. Nature communications, 10 (1), 1787. doi:10.1038/s41467-019-09853-z Peer reviewed |
 | Schuster, A., Erasimus, H. L. N., FRITAH, S., Nazarov, P., van Dyck, E., NICLOU, S. P., & GOLEBIEWSKA, A. (January 2019). RNAi/CRISPR Screens: from a Pool to a Valid Hit. Trends in Biotechnology, 37 (1), 38–55. doi:10.1016/j.tibtech.2018.08.002 Peer Reviewed verified by ORBi |
 | PAVLOU, M. A., GRANDBARBE, L., Buckley, N., NICLOU, S., & MICHELUCCI, A. (2018). Transcriptional and epigenetic mechanisms underlying astrocyte identity. Progress in Neurobiology. doi:10.1016/j.pneurobio.2018.12.007 Peer Reviewed verified by ORBi |
 | NICLOU, S. P. (09 October 2018). Revival of the VEGF ligand family? Neuro-Oncology, 20 (11), 1421-1422. doi:10.1093/neuonc/noy127 Peer Reviewed verified by ORBi |
 | Obad, N., Espedal, H., Jirik, R., Sakariassen, P. O., Brekke Rygh, C., Lund-Johansen, M., Taxt, T., NICLOU, S. P., Bjerkvig, R., & Keunen, O. (October 2018). Lack of functional normalisation of tumour vessels following anti-angiogenic therapy in glioblastoma. Journal of Cerebral Blood Flow and Metabolism, 38 (10), 1741-1753. doi:10.1177/0271678X17714656 Peer Reviewed verified by ORBi |
 | SOUSA, C., Golebiewska, A., Poovathingal, S. K., Kaoma, T., Pires-Afonso, Y., Martina, S., COOWAR, D., Azuaje, F., SKUPIN, A., BALLING, R., Biber, K., NICLOU, S., & MICHELUCCI, A. (2018). Single-cell transcriptomics reveals distinct inflammation-induced microglia signatures. EMBO Reports. doi:10.15252/embr.201846171 Peer Reviewed verified by ORBi |
 | Dudvarski Stanković, N., Bicker, F., Keller, S., Jones, D. T., Harter, P. N., Kienzle, A., Gillmann, C., Arnold, P., GOLEBIEWSKA, A., Keunen, O., Giese, A., von Deimling, A., Bäuerle, T., NICLOU, S. P., MITTELBRONN, M., Ye, W., Pfister, S. M., & Schmidt, M. H. (September 2018). EGFL7 enhances surface expression of integrin α(5)β(1) to promote angiogenesis in malignant brain tumors. EMBO Molecular Medicine, 10 (9). doi:10.15252/emmm.201708420 Peer Reviewed verified by ORBi |
 | Mäder, L., Blank, A. E., Capper, D., Jansong, J., Baumgarten, P., Wirsik, N. M., Zachskorn, C., Ehlers, J., Seifert, M., KLINK, B., Liebner, S., NICLOU, S. P., Naumann, U., Harter, P. N., & MITTELBRONN, M. (08 May 2018). Pericytes/vessel-associated mural cells (VAMCs) are the major source of key epithelial-mesenchymal transition (EMT) factors SLUG and TWIST in human glioma. Oncotarget, 9 (35), 24041-24053. doi:10.18632/oncotarget.25275 Peer Reviewed verified by ORBi |
 | MEISER, J., Schuster, A., Pietzke, M., Vande Voorde, J., Athineos, D., Oizel, K., Burgos-Barragan, G., Wit, N., Dhayade, S., Morton, J. P., Dornier, E., Sumpton, D., Mackay, G. M., Blyth, K., Patel, K. J., NICLOU, S. P., & Vazquez, A. (10 April 2018). Increased formate overflow is a hallmark of oxidative cancer. Nature Communications, 9 (1), 1368. doi:10.1038/s41467-018-03777-w Peer Reviewed verified by ORBi |
 | Wierz, M., Pierson, S., Guyonnet, L., VIRY, E., Lequeux, A., Oudin, A., NICLOU, S. P., OLLERT, M., BERCHEM, G. J. M. J., JANJI, B., Guérin, C., PAGGETTI, J., & MOUSSAY, E. (05 April 2018). Dual PD1/LAG3 immune checkpoint blockade limits tumor development in a murine model of chronic lymphocytic leukemia. Blood, 131 (14), 1617-1621. doi:10.1182/blood-2017-06-792267 Peer Reviewed verified by ORBi |
 | AZUAJE, F., Kaoma, T., Jeanty, C., NAZAROV, P., Muller, A., Kim, S.-Y., DITTMAR, G., GOLEBIEWSKA, A., & NICLOU, S. P. (2018). Hub genes in a pan-cancer co-expression network show potential for predicting drug responses. F1000Research, 7, 1906. doi:10.12688/f1000research.17149.2 Peer Reviewed verified by ORBi |
 | Fack, F., Tardito, S., Hochart, G., Oudin, A., Zheng, L., FRITAH, S., GOLEBIEWSKA, A., Nazarov, P., Bernard, A., Hau, A.-C., Keunen, O., Leenders, W., Lund-Johansen, M., Stauber, J., Gottlieb, E., Bjerkvig, R., & NICLOU, S. P. (October 2017). Altered metabolic landscape in IDH-mutant gliomas affects phospholipid, energy, and oxidative stress pathways. EMBO Molecular Medicine, 9 (12), 1681–1695. doi:10.15252/emmm.201707729 Peer Reviewed verified by ORBi |
 | Abdul Rahim, S. A., Dirkse, A., Oudin, A., Schuster, A., BOHLER, J., Barthelemy, V., Muller, A., Vallar, L., JANJI, B., GOLEBIEWSKA, A., & NICLOU, S. P. (05 September 2017). Regulation of hypoxia-induced autophagy in glioblastoma involves ATG9A. British Journal of Cancer, 117 (6), 813-825. doi:10.1038/bjc.2017.263 Peer Reviewed verified by ORBi |
 | Neirinckx, V., Hedman, H., & NICLOU, S. P. (August 2017). Harnessing LRIG1-mediated inhibition of receptor tyrosine kinases for cancer therapy. Biochimica et Biophysica Acta. Reviews on Cancer, 1868 (1), 109-116. doi:10.1016/j.bbcan.2017.02.007 Peer Reviewed verified by ORBi |
 | Armento, A., ILINA, E., Kaoma, T., Muller, A., Vallar, L., NICLOU, S. P., Krüger, M. A., MITTELBRONN, M., & Naumann, U. (August 2017). Carboxypeptidase E transmits its anti-migratory function in glioma cells via transcriptional regulation of cell architecture and motility regulating factors. International Journal of Oncology, 51 (2), 702-714. doi:10.3892/ijo.2017.4051 Peer Reviewed verified by ORBi |
Monaco, I., Camorani, S., Colecchia, D., Locatelli, E., Calandro, P., Oudin, A., NICLOU, S. P., Arra, C., Chiariello, M., Cerchia, L., & Comes Franchini, M. (25 May 2017). Aptamer Functionalization of Nanosystems for Glioblastoma Targeting through the Blood-Brain Barrier. Journal of Medicinal Chemistry, 60 (10), 4510-4516. doi:10.1021/acs.jmedchem.7b00527 Peer Reviewed verified by ORBi |
 | Talasila, K. M., Røsland, G. V., Hagland, H. R., Eskilsson, E., Flønes, I. H., FRITAH, S., AZUAJE, F., Atai, N., Harter, P. N., MITTELBRONN, M., Andersen, M., Joseph, J. V., Hossain, J. A., Vallar, L., Noorden, C. J. F. V., NICLOU, S. P., Thorsen, F., Tronstad, K. J., Tzoulis, C., ... Miletic, H. (01 March 2017). The angiogenic switch leads to a metabolic shift in human glioblastoma. Neuro-Oncology, 19 (3), 383-393. doi:10.1093/neuonc/now175 Peer Reviewed verified by ORBi |
Eskilsson, E., Rosland, G. V., Talasila, K. M., Knappskog, S., Keunen, O., Sottoriva, A., Foerster, S., Solecki, G., Taxt, T., Jirik, R., FRITAH, S., Harter, P. N., Välk, K., Al Hossain, J., Joseph, J. V., Jahedi, R., Saed, H. S., Piccirillo, S. G., Spiteri, I., ... Miletic, H. (December 2016). EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activation. Neuro-Oncology, 18 (12), 1644 - 1655. doi:10.1093/neuonc/now113 Peer Reviewed verified by ORBi |
 | Rodius, S., ANDROSOVA, G., Götz, L., Liechti, R., CRESPO, I., Merz, S., Nazarov, P., de Klein, N., Jeanty, C., González-Rosa, J., Muller, A., Bernardin, F., NICLOU, S., Vallar, L., Mercader, N., Ibberson, M., Xenarios, I., & Azuaje, F. (31 May 2016). Analysis of the dynamic co-expression network of heart regeneration in the zebrafish. Scientific Reports, 6. doi:10.1038/srep26822 Peer Reviewed verified by ORBi |
 | Bougnaud, S., GOLEBIEWSKA, A., Oudin, A., Keunen, O., Harter, P. N., Mäder, L., AZUAJE, F., FRITAH, S., Stieber, D., Kaoma, T., Vallar, L., Brons, N. H. C., Daubon, T., Miletic, H., Sundstrøm, T., Herold-Mende, C., MITTELBRONN, M., Bjerkvig, R., & NICLOU, S. P. (31 May 2016). Molecular crosstalk between tumour and brain parenchyma instructs histopathological features in glioblastoma. Oncotarget, 7 (22), 31955 - 31971. doi:10.18632/oncotarget.7454 Peer Reviewed verified by ORBi |
 | Demeure, K., Fack, F., DURIEZ, E., Tiemann, K., Bernard, A., GOLEBIEWSKA, A., Bougnaud, S., Bjerkvig, R., Domon, B., & NICLOU, S. P. (February 2016). Targeted Proteomics to Assess the Response to Anti-Angiogenic Treatment in Human Glioblastoma (GBM). Molecular and Cellular Proteomics, 15 (2), 481-92. doi:10.1074/mcp.M115.052423 Peer Reviewed verified by ORBi |
Du Four, S., Maenhout, S. K., NICLOU, S. P., Thielemans, K., Neyns, B., & Aerts, J. L. (2016). Combined VEGFR and CTLA-4 blockade increases the antigen-presenting function of intratumoral DCs and reduces the suppressive capacity of intratumoral MDSCs. American Journal of Cancer Research, 6 (11), 2514-2531. Peer reviewed |
Tardito, S., Oudin, A., Ahmed, S. U., Fack, F., Keunen, O., Zheng, L., Miletic, H., Sakariassen, P. Ø., Weinstock, A., Wagner, A., Lindsay, S. L., Hock, A. K., Barnett, S. C., Ruppin, E., Mørkve, S. H., Lund-Johansen, M., Chalmers, A. J., Bjerkvig, R., NICLOU, S. P., & Gottlieb, E. (December 2015). Glutamine synthetase activity fuels nucleotide biosynthesis and supports growth of glutamine-restricted glioblastoma. Nature Cell Biology, 17 (12), 1556 - 1568. doi:10.1038/ncb3272 Peer Reviewed verified by ORBi |
Burtey, A., Wagner, M., Hodneland, E., Skaftnesmo, K. O., Schoelermann, J., Mondragon, I. R., Espedal, H., GOLEBIEWSKA, A., NICLOU, S. P., Bjerkvig, R., Kögel, T., & Gerdes, H.-H. (November 2015). Intercellular transfer of transferrin receptor by a contact-, Rab8-dependent mechanism involving tunneling nanotubes. FASEB Journal, 29 (11), 4695-712. doi:10.1096/fj.14-268615 Peer Reviewed verified by ORBi |
 | NICLOU, S. P. (July 2015). Gauging heterogeneity in primary versus recurrent glioblastoma. Neuro-Oncology, 17 (7), 907-9. doi:10.1093/neuonc/nov078 Peer Reviewed verified by ORBi |
 | Du Four, S., Maenhout, S. K., De Pierre, K., Renmans, D., NICLOU, S. P., Thielemans, K., Neyns, B., & Aerts, J. L. (April 2015). Axitinib increases the infiltration of immune cells and reduces the suppressive capacity of monocytic MDSCs in an intracranial mouse melanoma model. Oncoimmunology, 4 (4), 998107. doi:10.1080/2162402X.2014.998107 Peer Reviewed verified by ORBi |
 | AZUAJE, F., Tiemann, K., & NICLOU, S. P. (31 March 2015). Therapeutic control and resistance of the EGFR-driven signaling network in glioblastoma. Cell Communication and Signaling, 13, 23. doi:10.1186/s12964-015-0098-6 Peer Reviewed verified by ORBi |
 | Waddell, N., Pajic, M., Patch, A.-M., Chang, D. K., Kassahn, K. S., Bailey, P., Johns, A. L., Miller, D., Nones, K., Quek, K., Quinn, M. C. J., Robertson, A. J., Fadlullah, M. Z. H., Bruxner, T. J. C., Christ, A. N., Harliwong, I., Idrisoglu, S., Manning, S., Nourse, C., ... Hair, J. (Other coll.). (26 February 2015). Whole genomes redefine the mutational landscape of pancreatic cancer. Nature, 518 (7540), 495-501. doi:10.1038/nature14169 Peer Reviewed verified by ORBi |
 | Fack, F., Espedal, H., Keunen, O., GOLEBIEWSKA, A., Obad, N., Harter, P. N., MITTELBRONN, M., Bähr, O., Weyerbrock, A., Stuhr, L., Miletic, H., Sakariassen, P. Ø., Stieber, D., Rygh, C. B., Lund-Johansen, M., Zheng, L., Gottlieb, E., NICLOU, S. P., & Bjerkvig, R. (January 2015). Bevacizumab treatment induces metabolic adaptation toward anaerobic metabolism in glioblastomas. Acta Neuropathologica, 129 (1), 115-31. doi:10.1007/s00401-014-1352-5 Peer Reviewed verified by ORBi |
 | Sanzey, M., Abdul Rahim, S. A., Oudin, A., Dirkse, A., Kaoma, T., Vallar, L., Herold-Mende, C., Bjerkvig, R., GOLEBIEWSKA, A., & NICLOU, S. P. (2015). Comprehensive analysis of glycolytic enzymes as therapeutic targets in the treatment of glioblastoma. PLoS ONE, 10 (5), 0123544. doi:10.1371/journal.pone.0123544 Peer Reviewed verified by ORBi |
 | FRITAH, S., NICLOU, S. P., & AZUAJE, F. (November 2014). Databases for lncRNAs: a comparative evaluation of emerging tools. RNA, 20 (11), 1655-65. doi:10.1261/rna.044040.113 Peer Reviewed verified by ORBi |
 | Bhujbal, S. V., de Haan, B., NICLOU, S. P., & de Vos, P. (31 October 2014). A novel multilayer immunoisolating encapsulation system overcoming protrusion of cells. Scientific Reports, 4, 6856. doi:10.1038/srep06856 Peer Reviewed verified by ORBi |
 | Keunen, O., Taxt, T., Grüner, R., Lund-Johansen, M., Tonn, J.-C., Pavlin, T., Bjerkvig, R., NICLOU, S. P., & Thorsen, F. (30 September 2014). Multimodal imaging of gliomas in the context of evolving cellular and molecular therapies. Advanced Drug Delivery Reviews, 76, 98-115. doi:10.1016/j.addr.2014.07.010 Peer Reviewed verified by ORBi |
 | ANDROSOVA, G., Rodius, S., Nazarov, P., Muller, A., Bernardin, F., Jeanty, C., NICLOU, S., Vallar, L., & Azuaje, F. (08 September 2014). A comprehensive integrative analysis of the transcriptional network underlying the zebrafish heart regeneration [Poster presentation]. European Conference on Computational Biology, Strasbourg, France. |
 | Bhujbal, S. V., Paredes-Juarez, G. A., NICLOU, S. P., & de Vos, P. (September 2014). Factors influencing the mechanical stability of alginate beads applicable for immunoisolation of mammalian cells. Journal of the Mechanical Behavior of Biomedical Materials, 37, 196-208. doi:10.1016/j.jmbbm.2014.05.020 Peer Reviewed verified by ORBi |
 | van Lith, S. A. M., Navis, A. C., Verrijp, K., NICLOU, S. P., Bjerkvig, R., Wesseling, P., Tops, B., Molenaar, R., van Noorden, C. J. F., & Leenders, W. P. J. (August 2014). Glutamate as chemotactic fuel for diffuse glioma cells: are they glutamate suckers? Biochimica et Biophysica Acta, 1846 (1), 66-74. doi:10.1016/j.bbcan.2014.04.004 Peer Reviewed verified by ORBi |
 | Torsvik, A., Stieber, D., Enger, P. Ø., GOLEBIEWSKA, A., Molven, A., Svendsen, A., Westermark, B., NICLOU, S. P., Olsen, T. K., Chekenya Enger, M., & Bjerkvig, R. (August 2014). U-251 revisited: genetic drift and phenotypic consequences of long-term cultures of glioblastoma cells. Cancer Medicine, 3 (4), 812-24. doi:10.1002/cam4.219 Peer Reviewed verified by ORBi |
 | Fathpour, P., Obad, N., Espedal, H., Stieber, D., Keunen, O., Sakariassen, P. Ø., NICLOU, S. P., & Bjerkvig, R. (May 2014). Bevacizumab treatment for human glioblastoma. Can it induce cognitive impairment? Neuro-Oncology, 16 (5), 754-6. doi:10.1093/neuonc/nou013 Peer Reviewed verified by ORBi |
Bhujbal, S. V., de Vos, P., & NICLOU, S. P. (April 2014). Drug and cell encapsulation: alternative delivery options for the treatment of malignant brain tumors. Advanced Drug Delivery Reviews, 67-68, 142-53. doi:10.1016/j.addr.2014.01.010 Peer Reviewed verified by ORBi |
 | Stieber, D., Golebiewska, A., Evers, L., Lenkiewicz, E., Brons, N. H. C., Nicot, N., Oudin, A., Bougnaud, S., HERTEL, F., Bjerkvig, R., Vallar, L., Barrett, M. T., & NICLOU, S. (2014). Glioblastomas are composed of genetically divergent clones with distinct tumourigenic potential and variable stem cell-associated phenotypes. Acta Neuropathologica, 127 (2), 203-19. doi:10.1007/s00401-013-1196-4 Peer Reviewed verified by ORBi |
 | Rajcevic, U., Knol, J. C., Piersma, S., Bougnaud, S., Fack, F., Sundlisaeter, E., Søndenaa, K., Myklebust, R., Pham, T. V., NICLOU, S. P., & Jiménez, C. R. (2014). Colorectal cancer derived organotypic spheroids maintain essential tissue characteristics but adapt their metabolism in culture. Proteome Science, 12, 39. doi:10.1186/1477-5956-12-39 Peer Reviewed verified by ORBi |
 | Demeure, K., DURIEZ, E., Domon, B., & NICLOU, S. P. (2014). PeptideManager: a peptide selection tool for targeted proteomic studies involving mixed samples from different species. Frontiers in Genetics, 5, 305. doi:10.3389/fgene.2014.00305 Peer Reviewed verified by ORBi |
 | BAGINSKA, J., VIRY, E., BERCHEM, G. J. M. J., Poli, A., Noman, M. Z., van Moer, K., Medves, S., ZIMMER, J., Oudin, A., NICLOU, S. P., Bleackley, R. C., Goping, I. S., Chouaib, S., & JANJI, B. (22 October 2013). Granzyme B degradation by autophagy decreases tumor cell susceptibility to natural killer-mediated lysis under hypoxia. Proceedings of the National Academy of Sciences of the United States of America, 110 (43), 17450-5. doi:10.1073/pnas.1304790110 Peer Reviewed verified by ORBi |
 | Johansson, M., Oudin, A., Tiemann, K., Bernard, A., GOLEBIEWSKA, A., Keunen, O., Fack, F., Stieber, D., Wang, B., Hedman, H., & NICLOU, S. P. (September 2013). The soluble form of the tumor suppressor Lrig1 potently inhibits in vivo glioma growth irrespective of EGF receptor status. Neuro-Oncology, 15 (9), 1200-11. doi:10.1093/neuonc/not054 Peer Reviewed verified by ORBi |
Kofanova, O. A., Fack, F., NICLOU, S. P., & BETSOU, F. (June 2013). Combined effect of tissue stabilization and protein extraction methods on phosphoprotein analysis. Biopreservation and Biobanking, 11 (3), 161-5. doi:10.1089/bio.2013.0008 Peer Reviewed verified by ORBi |
 | Daphu, I., Sundstrøm, T., Horn, S., Huszthy, P. C., NICLOU, S. P., Sakariassen, P. Ø., Immervoll, H., Miletic, H., Bjerkvig, R., & Thorsen, F. (June 2013). In vivo animal models for studying brain metastasis: value and limitations. Clinical and Experimental Metastasis, 30 (5), 695-710. doi:10.1007/s10585-013-9566-9 Peer Reviewed verified by ORBi |
 | Navis, A. C., NICLOU, S. P., Fack, F., Stieber, D., van Lith, S., Verrijp, K., Wright, A., Stauber, J., Tops, B., Otte-Holler, I., Wevers, R. A., van Rooij, A., Pusch, S., von Deimling, A., Tigchelaar, W., van Noorden, C. J. F., Wesseling, P., & Leenders, W. P. J. (29 May 2013). Increased mitochondrial activity in a novel IDH1-R132H mutant human oligodendroglioma xenograft model: in situ detection of 2-HG and α-KG. Acta Neuropathologica Communications, 1, 18. doi:10.1186/2051-5960-1-18 Peer Reviewed verified by ORBi |
 | Talasila, K. M., Soentgerath, A., Euskirchen, P., Rosland, G. V., Wang, J., Huszthy, P. C., Prestegarden, L., Skaftnesmo, K. O., Sakariassen, P. Ø., Eskilsson, E., Stieber, D., Keunen, O., Brekka, N., Moen, I., Nigro, J. M., Vintermyr, O. K., Lund-Johansen, M., NICLOU, S. P., Mørk, S. J., ... Miletic, H. (May 2013). EGFR wild-type amplification and activation promote invasion and development of glioblastoma independent of angiogenesis. Acta Neuropathologica, 125 (5), 683-98. doi:10.1007/s00401-013-1101-1 Peer Reviewed verified by ORBi |
 | Golebiewska, A., Bougnaud, S., Stieber, D., Brons, N. H. C., Vallar, L., HERTEL, F., Klink, B., Schrock, E., Bjerkvig, R., & NICLOU, S. (2013). Side population in human glioblastoma is non-tumorigenic and characterizes brain endothelial cells. Brain: a Journal of Neurology, 136 (Pt 5), 1462-75. doi:10.1093/brain/awt025 Peer Reviewed verified by ORBi |
 | Talasila, K. M., Brekka, N., Mangseth, K., Stieber, D., Evensen, L., Rosland, G. V., Torsvik, A., Wagner, M., NICLOU, S. P., Mahesparan, R., Vintermyr, O. K., Bjerkvig, R., Nigro, J. M., & Miletic, H. (2013). Tumor versus stromal cells in culture--survival of the fittest? PLoS ONE, 8 (12), 81183. doi:10.1371/journal.pone.0081183 Peer Reviewed verified by ORBi |
 | Petersen, K., Rajcevic, U., Abdul Rahim, S. A., Jonassen, I., Kalland, K.-H., Jimenez, C. R., Bjerkvig, R., & NICLOU, S. P. (2013). Gene set based integrated data analysis reveals phenotypic differences in a brain cancer model. PLoS ONE, 8 (7), 68288. doi:10.1371/journal.pone.0068288 Peer Reviewed verified by ORBi |
B, K., H, M., D, S., PC, H., JAC, V., J, B., J, W., M, S., PØ, S., T, S., A, T., M, A., JM, N., & NICLOU, S. P. (2013). Correction: A Novel, Diffusely Infiltrative Xenograft Model of Human Anaplastic Oligodendroglioma with Mutations in FUBP1, CIC, and IDH1. PLoS ONE. doi:10.1371/annotation/72a01ce5-b0ad-4cbd-ac77-0a81347a3940 Peer Reviewed verified by ORBi |
B, K., H, M., D, S., PC, H., JA, C., J, B., J, W., M, S., PØ, S., T, S., A, T., M, A., JM, N., & NICLOU, S. P. (2013). A novel, diffusely infiltrative xenograft model of human anaplastic oligodendroglioma with mutations in FUBP1, CIC, and IDH1. PLoS ONE. doi:10.1371/journal.pone.0059773 Peer Reviewed verified by ORBi |
 | Huszthy, P. C., Daphu, I., NICLOU, S. P., Stieber, D., Nigro, J. M., Sakariassen, P. Ø., Miletic, H., Thorsen, F., & Bjerkvig, R. (August 2012). In vivo models of primary brain tumors: pitfalls and perspectives. Neuro-Oncology, 14 (8), 979-93. doi:10.1093/neuonc/nos135 Peer Reviewed verified by ORBi |
 | Viel, T., Talasila, K. M., Monfared, P., Wang, J., Jikeli, J. F., Waerzeggers, Y., Neumaier, B., Backes, H., Brekka, N., Thorsen, F., Stieber, D., NICLOU, S. P., Winkeler, A., Tavitian, B., Hoehn, M., Bjerkvig, R., Miletic, H., & Jacobs, A. H. (July 2012). Analysis of the growth dynamics of angiogenesis-dependent and -independent experimental glioblastomas by multimodal small-animal PET and MRI. Journal of Nuclear Medicine, 53 (7), 1135-45. doi:10.2967/jnumed.111.101659 Peer Reviewed verified by ORBi |
Stieber, D., Abdul Rahim, S. A., & NICLOU, S. P. (October 2011). Novel ways to target brain tumour metabolism. Expert Opinion on Therapeutic Targets, 15 (10), 1227-39. doi:10.1517/14728222.2011.588211 Peer Reviewed verified by ORBi |
 | Keunen, O., Johansson, M., Oudin, A., Sanzey, M., Rahim, S. A. A., Fack, F., Thorsen, F., Taxt, T., Bartos, M., Jirik, R., Miletic, H., Wang, J., Stieber, D., Stuhr, L., Moen, I., Rygh, C. B., Bjerkvig, R., & NICLOU, S. P. (01 March 2011). Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma. Proceedings of the National Academy of Sciences of the United States of America, 108 (9), 3749-54. doi:10.1073/pnas.1014480108 Peer Reviewed verified by ORBi |
 | GOLEBIEWSKA, A., Brons, N. H. C., Bjerkvig, R., & NICLOU, S. P. (04 February 2011). Critical appraisal of the side population assay in stem cell and cancer stem cell research. Cell Stem Cell, 8 (2), 136-47. doi:10.1016/j.stem.2011.01.007 Peer Reviewed verified by ORBi |
 | Goplen, D., Bougnaud, S., Rajcevic, U., Bøe, S. O., Skaftnesmo, K. O., Voges, J., Enger, P. Ø., Wang, J., Tysnes, B. B., Laerum, O. D., NICLOU, S. P., & Bjerkvig, R. (October 2010). αB-crystallin is elevated in highly infiltrative apoptosis-resistant glioblastoma cells. American Journal of Pathology, 177 (4), 1618-28. doi:10.2353/ajpath.2010.090063 Peer Reviewed verified by ORBi |
 | NICLOU, S. P., Fack, F., & Rajcevic, U. (10 September 2010). Glioma proteomics: status and perspectives. Journal of Proteomics, 73 (10), 1823-38. doi:10.1016/j.jprot.2010.03.007 Peer Reviewed verified by ORBi |
 | Ehlert, E. M., Eggers, R., NICLOU, S. P., & Verhaagen, J. (18 February 2010). Cellular toxicity following application of adeno-associated viral vector-mediated RNA interference in the nervous system. BMC Neuroscience, 11, 20. doi:10.1186/1471-2202-11-20 Peer Reviewed verified by ORBi |
 | Rajcevic, U., Petersen, K., Knol, J. C., Loos, M., Bougnaud, S., Klychnikov, O., Li, K. W., Pham, T. V., Wang, J., Miletic, H., Peng, Z., Bjerkvig, R., Jimenez, C. R., & NICLOU, S. P. (November 2009). iTRAQ-based proteomics profiling reveals increased metabolic activity and cellular cross-talk in angiogenic compared with invasive glioblastoma phenotype. Molecular and Cellular Proteomics, 8 (11), 2595-612. doi:10.1074/mcp.M900124-MCP200 Peer Reviewed verified by ORBi |
 | Bjerkvig, R., Johansson, M., Miletic, H., & NICLOU, S. P. (October 2009). Cancer stem cells and angiogenesis. Seminars in Cancer Biology, 19 (5), 279-84. doi:10.1016/j.semcancer.2009.09.001 Peer Reviewed verified by ORBi |
Miletic, H., NICLOU, S. P., Johansson, M., & Bjerkvig, R. (April 2009). Anti-VEGF therapies for malignant glioma: treatment effects and escape mechanisms. Expert Opinion on Therapeutic Targets, 13 (4), 455-68. doi:10.1517/14728220902806444 Peer Reviewed verified by ORBi |
 | Rajcevic, U., NICLOU, S. P., & Jimenez, C. R. (01 January 2009). Proteomics strategies for target identification and biomarker discovery in cancer. doi:10.2741/3452 Peer reviewed |
 | Johansson, U., Rasmusson, I., NICLOU, S. P., Forslund, N., Gustavsson, L., Nilsson, B., Korsgren, O., & Magnusson, P. U. (September 2008). Formation of composite endothelial cell-mesenchymal stem cell islets: a novel approach to promote islet revascularization. Diabetes, 57 (9), 2393-401. doi:10.2337/db07-0981 Peer Reviewed verified by ORBi |
 | NICLOU, S. P., Danzeisen, C., Eikesdal, H. P., Wiig, H., Brons, N. H. C., Poli, A. M. F., Svendsen, A., Torsvik, A., Enger, P. Ø., Terzis, J. A., & Bjerkvig, R. (September 2008). A novel eGFP-expressing immunodeficient mouse model to study tumor-host interactions. FASEB Journal, 22 (9), 3120-8. doi:10.1096/fj.08-109611 Peer Reviewed verified by ORBi |
Terzis, A. J. A., NICLOU, S. P., Rajcevic, U., Danzeisen, C., & Bjerkvig, R. (August 2006). Cell therapies for glioblastoma. Expert Opinion on Biological Therapy, 6 (8), 739-49. doi:10.1517/14712598.6.8.739 Peer Reviewed verified by ORBi |
F, D., T, V., FJ, S., LA, W., PR, B., van Muiswinkel FL, J, V., & NICLOU, S. P. (2006). The expression of the chemorepellent Semaphorin 3A is selectively induced in terminal Schwann cells of a subset of neuromuscular synapses that display limited anatomical plasticity and enhanced vulnerability in motor neuron disease. Molecular and Cellular Neuroscience. doi:10.1016/j.mcn.2006.03.002 Peer Reviewed verified by ORBi |
HH, M., S, C., NICLOU, S. P., RS, N., A, W., MG, W., KE, R., MG, S., & A, C. (2006). A novel role for Sema3A in neuroprotection from injury mediated by activated microglia. Journal of Neuroscience. doi:10.1523/jneurosci.0702-05.2006 Peer Reviewed verified by ORBi |
 | Hu, Y., Leaver, S. G., Plant, G. W., Hendriks, W. T. J., NICLOU, S. P., Verhaagen, J., Harvey, A. R., & Cui, Q. (June 2005). Lentiviral-mediated transfer of CNTF to schwann cells within reconstructed peripheral nerve grafts enhances adult retinal ganglion cell survival and axonal regeneration. Molecular Therapy, 11 (6), 906-15. doi:10.1016/j.ymthe.2005.01.016 Peer Reviewed verified by ORBi |
Sinnreich, M., Meins, M., NICLOU, S. P., Suidan, H. S., & Monard, D. (March 2004). Prothrombin overexpressed in post-natal neurones requires blood factors for activation in the mouse brain. Journal of Neurochemistry, 88 (6), 1380-8. doi:10.1046/j.1471-4159.2003.02268.x Peer Reviewed verified by ORBi |
 | Ahmed, B. Y., Chakravarthy, S., Eggers, R., Hermens, W. T. J. M. C., Zhang, J. Y., NICLOU, S. P., Levelt, C., Sablitzky, F., Anderson, P. N., Lieberman, A. R., & Verhaagen, J. (30 January 2004). Efficient delivery of Cre-recombinase to neurons in vivo and stable transduction of neurons using adeno-associated and lentiviral vectors. BMC Neuroscience, 5, 4. doi:10.1186/1471-2202-5-4 Peer Reviewed verified by ORBi |
 | NICLOU, S. P., Franssen, E. H. P., Ehlert, E. M. E., Taniguchi, M., & Verhaagen, J. (December 2003). Meningeal cell-derived semaphorin 3A inhibits neurite outgrowth. Molecular and Cellular Neuroscience, 24 (4), 902-12. doi:10.1016/s1044-7431(03)00243-4 Peer Reviewed verified by ORBi |
 | Shearer, M. C., NICLOU, S. P., Brown, D., Asher, R. A., Holtmaat, A. J. G. D., Levine, J. M., Verhaagen, J., & Fawcett, J. W. (December 2003). The astrocyte/meningeal cell interface is a barrier to neurite outgrowth which can be overcome by manipulation of inhibitory molecules or axonal signalling pathways. Molecular and Cellular Neuroscience, 24 (4), 913-25. doi:10.1016/j.mcn.2003.09.004 Peer Reviewed verified by ORBi |
 | Ruitenberg, M. J., Plant, G. W., Christensen, C. L., Blits, B., NICLOU, S. P., Harvey, A. R., Boer, G. J., & Verhaagen, J. (January 2002). Viral vector-mediated gene expression in olfactory ensheathing glia implants in the lesioned rat spinal cord. Gene Therapy, 9 (2), 135-46. doi:10.1038/sj.gt.3301626 Peer Reviewed verified by ORBi |
 | NICLOU, S. P., Jia, L., & Raper, J. A. (01 July 2000). Slit2 is a repellent for retinal ganglion cell axons. Journal of Neuroscience, 20 (13), 4962-74. doi:10.1523/JNEUROSCI.20-13-04962.2000 Peer Reviewed verified by ORBi |
NICLOU, S. P., Suidan, H. S., Pavlik, A., Vejsada, R., & Monard, D. (May 1998). Changes in the expression of protease-activated receptor 1 and protease nexin-1 mRNA during rat nervous system development and after nerve lesion. European Journal of Neuroscience, 10 (5), 1590-607. doi:10.1046/j.1460-9568.1998.00183.x Peer Reviewed verified by ORBi |
 | Suidan, H. S., NICLOU, S. P., Dreessen, J., Beltraminelli, N., & Monard, D. (15 November 1996). The thrombin receptor is present in myoblasts and its expression is repressed upon fusion. Journal of Biological Chemistry, 271 (46), 29162-9. doi:10.1074/jbc.271.46.29162 Peer Reviewed verified by ORBi |
Suidan, H. S., Clemetson, K. J., Brown-Luedi, M., NICLOU, S. P., Clemetson, J. M., Tschopp, J., & Monard, D. (01 May 1996). The serine protease granzyme A does not induce platelet aggregation but inhibits responses triggered by thrombin. Biochemical Journal, 315 ( Pt 3) (Pt 3), 939-45. doi:10.1042/bj3150939 Peer Reviewed verified by ORBi |
Suidan, H. S., NICLOU, S. P., & Monard, D. (1996). The thrombin receptor in the nervous system. Seminars in Thrombosis and Hemostasis, 22 (2), 125-33. doi:10.1055/s-2007-998999 Peer Reviewed verified by ORBi |